ArticleTrials2025
The utility of pericapsular nerve group (PENG) block versus intrathecal morphine for postoperative analgesia in anterior approach total hip arthroplasty: a multicentre triple blinded randomised controlled trial protocol.
Article in Trials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundThe pericapsular nerve group (PENG) block is a novel regional technique for hip analgesia. Traditionally, intrathecal morphine has been administered for analgesia in hip fracture surgery. Compared with intrathecal morphine, the PENG block may provide superior or equivalent pain score reduction with a more favourable side effect profile and superior patient satisfaction.
methodsThis is a multicentre blinded randomised controlled trial (RCT) that is being conducted at present at two large teaching institutions in Australia. The pericapsular nerve group block (PENG block) shall be compared to low-dose intrathecal morphine for analgesic effect in elective total Hip arthroplasty via the direct anterior approach. Primary outcome shall be dynamic pain score evaluation at 3 and 24 h postoperatively. DISCUSSION: This is the protocol of our RCT which is currently in the early stages of active recruitment.
trial registrationEthics approval was obtained from the Southern Area Local Health Network prior to recruitment of the first patient. This trial was prospectively registered prior to initiation on the Australian and New Zealand Clinical Trials Registry. Australian New Zealand Clinical Trial Registry, ACTRN12623001309673P, 15/12/23, https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=386688&showOriginal=true&isReview=true .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.